DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0235782 | Gallbladder Carcinoma | SPHK1 | 8877 | sphingosine kinase 1 | Q9NYA1 |
C0079731 | B-Cell Lymphomas | SPHK1 | 8877 | sphingosine kinase 1 | Q9NYA1 |
C0235974 | Pancreatic carcinoma | SPHK1 | 8877 | sphingosine kinase 1 | Q9NYA1 |
C0018213 | Graves Disease | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0265221 | Walker-Warburg congenital muscular dystrophy | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0036341 | Schizophrenia | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0027651 | Neoplasms | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0027051 | Myocardial Infarction | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0376358 | Malignant neoplasm of prostate | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0033860 | Psoriasis | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0007138 | Carcinoma, Transitional Cell | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0400966 | Non-alcoholic Fatty Liver Disease | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0011854 | Diabetes Mellitus, Insulin-Dependent | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0026764 | Multiple Myeloma | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0020676 | Hypothyroidism | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0027651 | Neoplasms | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0027651 | Neoplasms | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C0013336 | Dwarfism | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C2239176 | Liver carcinoma | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C0006826 | Malignant Neoplasms | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C0023418 | leukemia | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C0026918 | Mycobacterium Infections | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C0003850 | Arteriosclerosis | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C0020542 | Pulmonary Hypertension | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C3463824 | MYELODYSPLASTIC SYNDROME | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024